| Literature DB >> 35909584 |
Abstract
Colorectal cancer is a common malignant tumor of the digestive system. In order to study the clinical efficacy of ultrasound-guided QLB and TAPB in the treatment and postoperative analgesia of patients undergoing laparoscopic colorectal surgery. A total of 96 patients undergoing laparoscopic colorectal surgery from January 2021 to January 2022 are selected as the study subjects. The results show that ultrasound-guided QLB and TAPB therapy have good analgesic effects in patients undergoing laparoscopic colorectal surgery, and QLB treatment and postoperative analgesic effect are better than TAPB.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35909584 PMCID: PMC9303504 DOI: 10.1155/2022/4199868
Source DB: PubMed Journal: Contrast Media Mol Imaging ISSN: 1555-4309 Impact factor: 3.009
Heart rate comparison.
| Group | Number | Preoperative (times/min) | Peel for 10 minutes (times/min) |
|
|
|---|---|---|---|---|---|
| QLB group | 48 | 64.13 ± 7.45 | 73.10 ± 7.11 | 1.418 | 0.002 |
| TAPB group | 48 | 65.36 ± 8.61 | 78.88 ± 8.75 | 2.145 | 0.011 |
|
| 2.474 | 3.014 | |||
|
| 0.659 | 0.032 |
Blood pressure contrast.
| Group | SBP (mmHG) | DBP (mmHG) | |
|---|---|---|---|
| Preoperative | QLB ( | 90.08 ± 3.26 | 68.51 ± 4.25 |
| TAPB ( | 89.36 ± 3.36 | 68.32 ± 4.56 | |
|
| |||
|
| 2.412 | 1.471 | |
|
| 0.061 | 0.464 | |
| Peel for 10 minutes | QLB ( | 102.03 ± 4.56 | 75.06 ± 4.02 |
| TAPB ( | 109.06 ± 4.32 | 79.15 ± 3.59 | |
|
| |||
|
| 2.964 | 2.454 | |
|
| 0.041 | 0.012 | |
Figure 1Heart rate and blood pressure.
Stress response after surgery.
| Group | Number | COR (nmol/L) | NK (%) |
|---|---|---|---|
| QLB group | 48 | 451.85 ± 90.03 | 22.43 ± 3.04 |
| TAPB group | 48 | 510.14 ± 88.62 | 17.17 ± 2.59 |
|
| 2.657 | 3.321 | |
|
| 0.016 | 0.022 |
The drug dosage.
| Group | Number | Remifentanil [ | Propofol [mg/(kg·h)] |
|---|---|---|---|
| QLB group | 48 | 0.15 ± 0.02 | 5.42 ± 1.01 |
| TAPB group | 48 | 0.19 ± 0.03 | 5.71 ± 1.04 |
|
| 0.541 | 0.965 | |
|
| 0.036 | 0.024 |
Comparison of VAS scores 1, 3, and 6 h after surgery.
| Group | Number | Before the surgery | 1 h after the surgery | 3 h after the surgery | 6 h after the surgery |
|
|
|---|---|---|---|---|---|---|---|
| QLB group | 48 | 6.27 ± 1.29 | 3.35 ± 0.12 | 2.21 ± 0.24 | 1.32 ± 0.04 | 0.747 | 0.015 |
| TAPB group | 48 | 6.21 ± 1.27 | 4.57 ± 0.24 | 3.13 ± 0.27 | 2.03 ± 0.17 | 1.447 | 0.022 |
|
| 0.321 | 0.476 | 0.853 | 0.412 | |||
|
| 0.617 | 0.043 | 0.026 | 0.003 |
Figure 2Comparison of VAS scores 1, 3, and 6h after surgery.
Comparison of the incidence of adverse reactions.
| Group | Number | Remedial analgesia (%) | Nausea and vomiting (%) | Blurred consciousness (%) |
|---|---|---|---|---|
| QLB group | 48 | 3 (6.25) | 5 (10.42) | 1 (2.08) |
| TAPB group | 48 | 8 (16.67) | 11 (22.92) | 2 (4.17) |
|
| 2.668 | 2.774 | 1.363 | |
|
| 0.004 | 0.001 | 0.052 |
Figure 3Comparison of the incidence of adverse reactions.